COVID-19 vaccine timeline: A look at what’s ahead for leading candidates
Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.
COVID-19 vaccine: Who will get the first doses?
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
Vaccine researcher discusses myths about COVID-19 vaccine
A COVID-19 vaccine could be approved within weeks, but half of Americans say they may give it a pass. A top researcher studying two of the current vaccine contenders says misconceptions about the experimental vaccine may be leaving Americans reluctant to try it.
AstraZeneca plans to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
ViralClear halts trial of experimental treatment for hospitalized COVID-19 patients
Citing “an imbalance in survival rates,” ViralClear said it would halt a trial for COVID-19 patients who were given a combination of two experimental drugs in order to treat severe symptoms.
Volunteer in AstraZeneca coronavirus clinical trial dies, report says
The volunteer was a man in his 20s, according to reports. It was not immediately clear if the man received the vaccine or had been part of a placebo group.
Federal health officials planning to get coronavirus shots to nursing homes
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
COVID-19 vaccine studies push for minority volunteers, but it's 'a hard sell'
As COVID-19 vaccine trials move forward at record speed, organizers are recruiting minority volunteers. It's a tough sell. But, Dr. Lisa Wynn and her husband Charles, both African American, decided to join Moderna's COVID-19 vaccine study, the COVE study, together.
Eli Lilly pauses COVID-19 antibody drug trial over potential safety concerns
The Eli Lilly drug is similar to one that President Donald Trump received from Regeneron Pharmaceuticals.
Johnson & Johnson vaccine trial paused over unexplained illness
A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot.
2nd coronavirus vaccine trial paused over unexplained illness
The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.